Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,239
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,844
Class I recallsReasonable probability of serious health consequences
24,383
Class II recallsTemporary or medically reversible health consequences
2,897
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,084 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eden-brothers-recalls-calabrese-broccoli-seeds-due-possible-salmonella-contaminationPublished October 7, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2

Showing 19,681–19,700 of 20,461 recalls

FDA Recall TerminatedTerminated: May 7, 2015Historical recordClass II

VECURONIUM Bromide for Injection, 10 mg* per vial, *1 mg per mL when reconstituted to 10 mL, for IV single use only, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195 (USA); Mfd. by MN Pharmaceuticals; Made in Turkey, NDC 25021-657-10.

by Sagent Pharmaceuticals Inc

Reason
CGMP Deviations: product was not manufactured under current good manufacturing practices which contributed to Failed Impurities/Degradation Specifications as a high out of specification impurity result was detected during routine quality testing of stability samples.
Published
June 26, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: May 13, 2016Historical recordClass III

HydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 16 fl. oz. (473 mL), Rx Only, HI-TECH PHARMACAL CO., INC. AMITYVILLE, NY, NDC 50383-796-16

by Hi-Tech Pharmacal Co., Inc.

Reason
Subpotent; 24 month stability test station
Published
June 26, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: March 18, 2014Historical recordClass III

Sodium Sulfacetamide 10% and Sulfur 5% Lotion, (NDC 42792-102-01), 25 g Manufactured for: Austin Pharmaceuticals, LLC, Wilmington, DE

by Mission Pharmacal Co

Reason
Superpotent: Drug product active ingredients were formulated incorrectly (too high) with respect to the label strength.
Published
June 26, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 29, 2016Historical recordClass I

Rugby NATURAL IRON SUPPLEMENT Ferrous Sulfate, 5 gr (325 mg), 100 TABLETS, Mfd for: RUGBY LABORATORIES, INC. DULUTH, GEORGIA 30097 UPC 0 0536-5890-013

by Advance Pharmaceutical Inc

Reason
Labeling; Label Mixup; bottles of Ferrous Sulfate actually contains Meclizine HCl (indicated for motion sickness)
Published
June 19, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 1, 2019Historical recordClass I

MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL

by OLAAX International

Reason
Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.
Published
June 19, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 9, 2014Historical recordClass III

Fentanyl Transdermal System, 50 mcg/h, 1 system per pouch (NDC 0591-3212-54), packaged in 5-count systems per box (NDC 0591-3212-72), Rx only, Manufactured by Watson Laboratories, Inc, Corona, CA, 92880 USA; Distributed by: Watson Pharma, Inc.

by Actavis

Reason
Failed Impurities/Degradation Specifications
Published
June 19, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 24, 2013Historical recordClass III

Amoxicillin for Oral Suspension, USP 400mg/5mL, NDC 0093-4161-78 (75ml) and 0093-4161-73 (100mL)

by Teva Pharmaceuticals USA, Inc.

Reason
Discoloration: This recall is being carried out due to a yellow to brown discolored Amoxicillin powder on the inner foil seal of the bottles.
Published
June 19, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 7, 2014Historical recordClass II

Cefazolin, injection, 1 gram per vial, 25 vials per box, sterile, Rx only, single-use vial, Manufactured in Austria by Sandoz GmbH for Sandoz, Inc. Princeton, NJ 08540, NDC 00781-3451-70 (vial), NDC 00781-3451-96 (box)

by Sandoz Incorporated

Reason
Lack of Assurance of Sterility: Sandoz Inc is recalling Cefazolin for Injection, USP 1 gm vials, lot DB2208, due to a customer complaint for broken/cracked vials which was confirmed through review of retained samples.
Published
June 19, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 1, 2013Historical recordClass III

Voltaren 1% Gel, 100 gm tube, Rx only, Dist By: Physicians Total Care, Tulsa OK 74146, Mfg By: Novartis Consumer Health, Parsippany, NJ 07054, NDC 54868-5965-00

by Physicians Total Care, Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Expiration Date; This recall is being initiated because the lot number and expiration date on the tube may not be legible.
Published
June 12, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 24, 2013Historical recordClass III

Disulfiram Tablets USP 250 mg, 100 tablet bottle, Rx only, Manufactured for TEVA Pharmaceuticals, USA, Sellersville, PA --- NDC 0093-5035-01

by Teva Pharmaceuticals USA, Inc.

Reason
CGMP Deviation; cotton coil is missing in some packaged bottles
Published
June 12, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 26, 2014Historical recordClass III

Voltaren Gel (diclofenac sodium topical gel) 1%, for topical use only, RX only, a) Packaged in 20 gm tubes, NDC 63481-684-83 (physician sample product) and b) 100 gm tubes, NDC 63481-684-47 (the 100 g tubes are also packaged 3/100-g tubes/packs (UPC code: 363481684030 NDC code: 6348168403) and 5/100-g tubes/packs (UPC code: 363481684054 NDC code: 6348168405), Marketed by Endo Pharmaceuticals Inc., Chadds Ford, PA and Manufactured by Novartis Consumer Health, Inc, Parsippany, NJ.

by Novartis Consumer Health

Reason
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
Published
June 12, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 26, 2014Historical recordClass III

Lamisil AT Cream (terbinafine hydrochloride 1% antifungal), 12 gm ( .42 oz) Tubes and 30 gm (1 oz) Tubes packaged in one box, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300676249438. (Club Pack), NDC 0067-6295-43

by Novartis Consumer Health

Reason
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
Published
June 12, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 26, 2014Historical recordClass III

Novartis Lamisil AT Cream for Jock Itch (terbinafine hydrochloride 1% antifungal), a) 12 g (.42 oz) Tube, NDC 0067-3999-12, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300673999121, (Vertical Pack) and b) packaged in a horizontal package12 gm (.42 oz) Tube, NDC 0067-3999-42, Novartis Consumer Health, Inc., Parsippany, NJ. UPC code: 300673999428.

by Novartis Consumer Health

Reason
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
Published
June 12, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 26, 2014Historical recordClass III

Target Up & Up, athlete's foot cream, full prescription strength, terbinafine hydrochloride 1% antifungal, 30 g (1 oz), compare to active ingredient in Lamisil, NDC 0067-6382-30 & UPC code: 300676382302 (Novartis) Target NDC 1167-3401-04, Distributed by Target Corp., Minneapolis, MN.

by Novartis Consumer Health

Reason
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot..
Published
June 12, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 26, 2014Historical recordClass III

Novartis Lamisil AT Cream, Terbinafine Hydrochloride Cream 1% Antifungal, Novartis Consumer Health, Inc., Parsippany, NJ. (a)12 gm (.42 oz), packaged with UPC code 300673998421 and NDC code: 0067-3998-42; (b) 12 gm (.42 oz), packaged with UPC code: 300673998124 and NDC code: 0067-3998-12; (c) 30 gm (1 oz), packaged with UPC code: 300673998308 and NDC code: 0067-3998-30; (d) 30 gm (1 oz), packaged with UPC code: 300673998339 and NDC code: 0067-3998-33.

by Novartis Consumer Health

Reason
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
Published
June 12, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Tri-Mix Injections in 5 mL and 10 mL vials (Alprostadil, Phentolamine and Papaverine), compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

MIC (Methionine, Inositol, and Choline) Injectable, 30 mL vials, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Praziquantel 56.8 mg, 50 mL vial, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Carnosine 5% Opth drop, 40 mL vial, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

FDA Recall TerminatedTerminated: September 30, 2024Historical recordClass II

Morphine Sulfate 25 mg/mL Injectable, 40 mL vial, compounded by The Compounding Shop, St. Petersburg, FL

by THE COMPOUNDING SHOP, INC.

Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published
June 12, 2013
Distribution
Florida, California, Minnesota, and Main…

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.